Download this guide to learn how to design ribs, bosses, and other features that stand the test of time, better ways to process LFT materials, what to do to minimize part defects and more about Complēt™ and OnForce™ Long Fiber Reinforced Thermoplastic Composites

Explore what's accelerating the adventure sports market and affecting product development, design and performance.

PP OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Dynaflex™ G2706 28A USP Class VI, ISO 10993, Food contact EtO Soft translucent grade, grippy feel Dynaflex™ G2711 43A USP Class VI, ISO 10993, Food contact EtO Highly colorable solution, grippy feel, low compression set Versaflex™ CL2242 & CL2250 42A/ 50A USP Class VI, ISO 10993, US Food contact EtO Clear boilable grades; ABS, PC bondable Versaflex™ G2705 N 60A USP Class VI, ISO 10993, Food contact EtO/Steam High resilience, low compression set Versaflex™ HC3810 20A-90A USP Class VI, ISO 10993 EtO General purpose, unfilled ABS, PC OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versaflex™ OM1040 40A USP Class VI, ISO 10993 EtO Translucent Versaflex™ OM3060 60A USP Class VI, ISO 10993 EtO Clear VERSAFLEX™ CL AND DYNAFLEX™ TPEs OVERMOLDING FOR ERGONOMICS • Adds good tactile surface with soft-touch feel • Available in a variety of color effects and textures • Improves grip, cushion, and comfort • Enhances functional performance like sealing properties, vibration damping, oxygen barrier, and scratch and abrasion resistance • Reduces assembly costs, good processability • Offers excellent adhesion to a wide range of substrates Applications: • Glucometers • Medical tools overmolds • Injector pens • Analysis devices VERSALLOY™ HC & VERSAFLEX™ HC TPEs SEALING & RESEALING • Rubbery feel and soft touch • No coring, good puncture, and resealability in static stoppers • Meets low coefficient of friction requirements in dynamic seals • Low extractables • Suitable to overmold onto polyolefins Applications: • Sealing and resealing septum • Seals and sanitary gaskets • Syringe plungers and tips MATERIAL DESCRIPTION HARDNESS REGULATORY STERILIZATION CHARACTERISTICS Versalloy™ HC 9210-45N 45A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-55N 55A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9210-70N 70A USP Class VI EtO Good processability, smooth surface aesthetics Versalloy™ HC 9220-43N 43A USP Class VI, ISO 10993-4/5 EtO Extrusion grade, high temperature resistance Versaflex™ HC 2110-35N 34A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Resealing, elevated comp set Versaflex™ HC 2110-57B 57A FDA, USP Class VI, ISO 10993 Autoclave EtO radiation Low stiction VERSAFLEX™ CL AND DYNAFLEX™ TPEs HIGH CLARITY GRADES WITHOUT PLASTICIZERS • Water clear grades formulated without phthalate plasticizers • Meets medical regulatory USP Class VI and ISO 10993-4,5 • Food contact and FDA compliant • Autoclave and radiation stable • Low extractable • High clarity (Haze 50 4.1, 100 4.5, 100 4, 70 6, 70 Tensile Modulus (MPa) 2200 2700 2600 2350 1820 1820 Flexural Strength (MPa) 80 90 104 86 68 68 Flexural Modulus (MPa) 2500 2700 2500 2300 1980 1590 HDT: 0.45, 1.8 (MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70 UL-94 Rating @ 3.0 mm 5VA V-0 5VA V-0 HB V-0 UL-94 Rating @ 1.5 mm V-0 V-0 5VB V-0 HB V-0 UL-94 Rating @ 0.75 mm V-1 V-2 V-0 None None V-2 COMPETITIVE MATERIAL COMPARISON ENGINEERED POLYMER FORMULATIONS FOR HEALTHCARE TRILLIANT™ HC THERMOPLASTICS The family of Trilliant™ HC high-performance thermoplastics is formulated to meet the growing challenges of medical devices and equipment.

Platform operating income mix percentage 2005Y 2008Y 2011Y Global Specialty Engineered Materials $ 0.4 $ 17.6 $ 45.9 Global Color, Additives and Inks 4.3 28.1 43.4 Specialty Platform $ 4.7 $ 45.7 $ 89.3 Performance Products and Solutions 75.7 31.3 62.4 Distribution 19.5 28.1 56.0 SunBelt Joint Venture 91.9 28.6 5.0 Corporate (51.5) (425.1) 20.3 Operating income (loss) GAAP $ 140.3 $ (291.4) $ 233.0 Less: Corporate operating expense (income) 51.5 425.1 (20.3) Operating income excluding Corporate $ 191.8 $ 133.7 $ 212.7 Specialty platform operating mix percentage 2% 34% 42% Pro forma platform operating income mix percentage 2007 Pro forma 2011Y Specialty Platform $ 30.6 $ 89.3 Pro forma ColorMatrix - 27.7 Specialty Platform pro forma ColorMatrix $ 30.6 $ 117.0 Performance Products and Solutions 65.8 62.4 Distribution 22.1 56.0 SunBelt Joint Venture 34.8 5.0 Corporate (73.3) 20.3 Operating income pro forma ColorMatrix $ 80.0 $ 260.7 Less: Corporate and SunBelt operating income 73.3 (25.3) Operating income excluding Corporate operating income $ 153.3 $ 235.4 Specialty platform operating mix percentage 20% 50% Adjusted EPS 2006Y 2007Y 2008Y 2009Y 2010Y 2011Y Net Income $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 162.6 $ 172.6 SunBelt and OxyVinyls equity earnings, after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) Special items, after tax (21.2) 41.4 310.0 (31.0) 15.8 (30.5) Tax adjustments (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 75.4 $ 96.1 Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.79 $ 1.02 Adjusted EPS Q1 2011 Q1 2012 Net Income $ 110.2 $ 20.2 SunBelt equity earnings, after tax (3.7) - Special items, after tax (79.8) 6.1 Tax adjustments (1.5) 0.1 Adjusted net income $ 25.2 $ 26.4 Diluted shares 96.4 90.7 Adjusted EPS $ 0.26 $ 0.29 Platform sales and operating income (OI) 2005 2006 2007 2008 2009 2010 2011 Global Specialty Engineered Materials Sales $ 282.5 $ 345.3 $ 384.4 $ 514.0 $ 402.9 $ 517.4 $ 575.1 Global Color, Additives and Inks Sales 503.7 531.8 560.5 554.3 459.8 527.4 544.6 Specialty Platform Sales $ 786.2 $ 877.1 $ 944.9 $ 1,068.3 $ 862.7 $ 1,044.8 $ 1,119.7 Performance Products and Solutions Sales 1,136.3 1,166.2 1,086.8 1,001.4 667.7 776.3 865.4 PolyOne Distribution Sales 679.2 732.8 744.3 796.7 625.1 911.9 996.5 Corporate and Eliminations (151.1) (153.7) (133.3) (127.7) (94.8) (111.1) (118.1) Total Sales $ 2,450.6 $ 2,622.4 $ 2,642.7 $ 2,738.7 $ 2,060.7 $ 2,621.9 $ 2,863.5 Pro forma ColorMatrix Sales 196.0 Total sales pro forma ColorMatrix $ 3,059.5 Global Specialty Engineered Materials OI $ 0.4 $ 3.9 $ 4.9 $ 17.6 $ 20.6 $ 49.7 $ 45.9 Global Color, Additives and Inks OI 4.3 8.9 25.7 28.1 25.2 37.7 43.4 Specialty Platform OI $ 4.7 $ 12.8 $ 30.6 $ 45.7 $ 45.8 $ 87.4 $ 89.3 Performance Products and Solutions OI 75.7 64.2 65.8 31.3 33.1 54.0 62.4 PolyOne Distribution OI 19.5 19.2 22.1 28.1 24.8 42.0 56.0 Sunbelt Joint Venture OI 91.9 102.9 34.8 28.6 25.5 18.9 5.0 Corporate and eliminations (21.8) (4.6) (25.5) (28.9) (40.8) (32.5) (26.4) Special items (29.7) 39.1 (47.8) (396.2) 48.7 4.8 46.7 Operating income (loss) GAAP $ 140.3 $ 233.6 $ 80.0 $ (291.4) $ 137.1 $ 174.6 $ 233.0 Sunbelt equity income (72.5) (107.0) (40.8) (32.5) (29.7) (23.1) (5.7) Special items 29.7 (39.1) 47.8 396.2 (48.7) (4.8) (46.7) Operating income adjusted $ 97.5 $ 87.5 $ 87.0 $ 72.3 $ 58.7 $ 146.7 $ 180.6 Operating income pro forma ColorMatrix 27.7 Operating income adjusted pro forma ColorMatrix $ 208.3 Global Specialty Engineered Materials - OI as a percentage of sales 0.1% 1.1% 1.3% 3.4% 5.1% 9.6% 8.0% Global Color, Additives and Inks - OI as a percentage of sales 0.9% 1.7% 4.6% 5.1% 5.5% 7.1% 8.0% Specialty platform OI as a percentage of sales 0.6% 1.5% 3.2% 4.3% 5.3% 8.4% 8.0% Specialty platform OI as a percentage of sales - pro forma ColorMatrix 8.9% Global Color, Additives and Inks OI as a percentage of sales – pro forma ColorMatrix 9.6% PP&S operating OI as a percentage of sales 6.7% 5.5% 6.1% 3.1% 5.0% 7.0% 7.2% Distribution OI as a percentage of sales 2.9% 2.6% 3.0% 3.5% 4.0% 4.6% 5.6% PolyOne OI adjusted, as a percentage of sales 4.0% 3.3% 3.3% 2.6% 2.8% 5.6% 6.3% PolyOne OI adjusted, pro forma for ColorMatrix, as a percent of sales 6.8% Operating income (OI) Q1 2011 Q1 2012 Global Specialty Engineered Materials OI $ 14.0 $ 11.8 Global Color, Additives and Inks OI 11.2 17.3 Specialty Platform OI $ 25.2 $ 29.1 Performance Products and Solutions OI 14.3 17.8 PolyOne Distribution OI 14.7 16.7 Corporate and eliminations (1.6) (10.2) Special items 127.2 (8.5) Operating income (loss) GAAP $ 179.8 $ 44.9 Research and Development (R&D) – Pro forma ColorMatrix 2011 PolyOne R&D $ 36.9 ColorMatrix R&D 3.6 Pro forma R&D $ 40.5 Gross Margin as a percentage of Sales 2006 2011 2011 Pro forma ColorMatrix Specialty platform sales $ 877.1 $ 1,119.7 $ 1,315.7 Specialty platform gross margin 125.2 263.4 345.9 Specialty platform gross margin percentage 14.3 % 23.5 % 26.3 % Average Debt Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne Debt $ 452.9 $ 432.9 $ 432.9 $ 432.9 $ 707.0 n/a Pro forma ColorMatrix 274.1 274.1 274.1 274.1 - n/a Total Debt $ 727.0 $ 707.0 $ 707.0 $ 707.0 $ 707.0 $ 711.0 Average Equity Q4 2010 Q1 2011 Q2 2011 Q3 2011 Q4 2011 Average PolyOne $ 516.0 $ 615.2 $ 629.6 $ 608.5 $ 588.3 $ 591.5

reSound™ OM Thermoplastic Elastomers Bio-based TPEs Deliver on Performance Designed to support sustainability goals, the reSound OM TPE formulations utilize between 40 and 50 percent bio-renewable content derived from sugarcane and offer hardness levels and property retention comparable to traditional petroleum-based TPEs.

PHTHALATES DO NOT EASILY MIGRATE They are often chosen for use because they don’t easily migrate out of materials. PHTHALATES FACTS PHTHALATES ARE KNOWN TO BREAK DOWN IN THE HUMAN BODY Research has shown that after entering the body, phthalate are broken down into metabolites within minutes and pass out quickly in urine.2 PHTHALATE EXPOSURE IS CONSIDERED LOW Despite the fact that phthalates are used in a wide range of products, human exposure from all sources is considered to be extremely low.2 PHTHALATES ARE A USEFUL CHOICE FOR HEALTHCARE Flexible vinyl tubing does not react with most medications, allowing for reliable administration of drugs, while flexible vinyl bags prevent blood contamination and extend shelf life of the blood.3 PHTHALATES ARE REGULATED Based on earlier studies, a few specific phthalates have been banned for use in toys or other items for sale to children under twelve to reduce risk of overexposure through hand-to- mouth behaviors. 1 Source: chemicalsafetyfacts.org 2 Source: Centers for Disease Control and Prevention 3 Source: thisisplastics.com www.avient.com Copyright © 2020, Avient Corporation.

Buyer assumes all risks and liabilities arising out of unloading, discharge, storage, handling and use of the Product, or arising out of compliance or non-compliance with applicable laws and regulations governing or controlling such activity. Except to the extent attributable to the Product sold hereunder failing to meet the express warranties set forth in paragraph 2, Buyer will indemnify, defend and hold Seller harmless from all costs, expenses, damages, judgments or other loss, including costs of investigation, litigation and reasonable attorney's fees, arising out of Buyer's selection, use, sale and further processing of the Product sold hereunder. If Buyer fails to disseminate such warnings and information, Buyer will indemnify, defend and save Seller harmless against any and all liability arising out of or in any way connected with such failure, including without limitation, liability for injury, sickness, death and property damage. 12.

Buyer assumes all risks and liabilities (i) arising out of unloading, discharge, storage, handling and use of the Product, or (ii) arising out of compliance Das Eigentum und das Verlustrisiko für das Produkt gehen am Versandort des Verkäufers auf den Käufer über. Buyer shall indemnify, defend and save Seller harmless against any and all liability for Buyer Indemnity Costs arising out of or in any way connected with Buyer’s failure to disseminate such information. The courts of Frankfurt/Main shall have exclusive jurisdiction with regard to dispute or lawsuit arising out of or in connection with these Terms.

Create Custom Views You can create custom views depending on what information you want to see relating to orders, invoices, catalogs, or ASNs.

S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013 10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?